Home Covance Sitemap

Covance Sitemap

Sitemap List

Industry Solutions

Drug Development

Drug Development Process by Phase | Covance

Proof of Concept Study in Clinical Research - PoC® Services | Covance

Drug Development Product Value Solutions | Covance

Molecule Development Group | Covance

Alliance Management Pharmaceutical Consulting | Covance

Phase IV Studies | Covance

Pharmaceutical Research and Drug Development | Covance

Molecule Development Group

Preclinical CRO, Studies and Testing | Covance Nonclinical

Molecule Development Group

Demonstrating Your Product Value

Preclinical CRO Testing Labs & Facilities | Covance Nonclinical

Shanghai Facility | Covance

Ann Arbor, MI Facility | Covance

Harrogate, UK Facility | Covance

Madison, WI Facility | Covance

Phase I Clinical Trials through Phase III Clinical Trials | Covance

Demonstrating Your Product Value

Molecule Development Group

Covance MarketPlace – Find the Right Partner for Your Drug Development Program | Covance

Early Phase Drug Development Solutions | Covance

Covance Drug Development Services

Drug Development Therapeutic or Specialty Areas | Covance

Cardiovascular Disease Drug Development | Covance

Dermatology Drug Development | Covance

Diabetes, Endocrinology and Nephrology | Covance

Infectious Diseases Drug Development

Infectious Diseases Education Center | Covance

Inflammation Drug Development Solutions

Inflammation Education Center

Rheumatoid Arthritis Drug Development Solutions | Covance

Respiratory Drug Development Solutions | Covance

NASH Liver Disease Drug Development | Covance

NASH Education Center

Neuroscience Drug Development | Covance

Oncology & Hematology Drug Development | Covance

Immuno-Oncology Drug Development Solutions | Covance

Immuno-Oncology Education Center

Oncology Education Center

Preclinical Pharmacology Oncology

Orphan Drug Development for Rare Diseases | Orphan Disease Testing

Orphan Disease Education Center | Covance

Rare Diseases Drug Development Solutions and Clinical Trials | Covance

Preclinical and Clinical Ophthalmic CRO Solutions | Covance

Pediatric Drug Development Solutions

Global contract research organization | Covance

Drug Development Services Australia | Covance

Life Cycle Management

Drug Development Services China | Covance

Life Cycle Management

Drug Development Services Hong Kong | Covance

Life Cycle Management

Drug Development Services India | Covance

Life Cycle Management

Drug Development Services Japan | Covance

Life Cycle Management

Drug Development Services Korea | Covance

Life Cycle Management

Drug Development Services Malaysia | Covance

Life Cycle Management

Drug Development Services New Zealand | Covance

Life Cycle Management

Drug Development Services Philippines | Covance

Life Cycle Management

Drug Development Services Singapore | Covance

Life Cycle Management

Drug Development Services Taiwan | Covance

Life Cycle Management

Drug Development Services Thailand | Covance

Life Cycle Management

Drug Discovery and Development - By Molecule Type | Covance

Biologics Solutions | Drug Development | Covance

Small Molecule Drug Discovery and Development

Biosimilars Development Solutions

Biosimilars Education Center

Cell and Gene Therapy Solutions | Covance

Healthcare Commercialization Services | Covance

Patient Services and Provider Services | Commercialization | Covance

Patient Assistance Programs | Covance

Patient Access Programs 2020 Events

Patient Assistance Solutions | Covance

Pharmacy Services | Healthcare Commercialization | Covance

Clinical Patient Help and Services | Covance

Adherence in Healthcare | Covance

Healthcare Technology | Covance

Patient Access Programs 2020 Events

Market Access Consulting | Healthcare Commercialization | Covance

Managed Markets Services | Healthcare Commercialization | Covance

Clinical Trial Optimization | Xcellerate® by Covance

Oncology Drug Development: Preclinical & Clinical | Covance

Preclinical Oncology CRO | Covance

Oncology Cell Lines | Covance Preclinical

786-O-LUC-NEO (RESCUED)

E.G7-OVA: Murine Thymic Lymphoma

SW 780 Human Bladder Carcinoma

NHDF (normal human dermal fibroblasts)

OVCAR-5: Human Ovarian Carcinoma

NCI-H3122: Human Lung Adenocarcinoma

NCI-H929-Luc-mCh-Puro Human Multiple Myeloma

Pan02: Murine pancreatic ductal adenocarcinoma

OVCAR-8: Human Ovarian Carcinoma

NCI-H460 Human Lung Carcinoma

U-87 MG-Luc: Human glioblastoma

SW-480: Human Colon Carcinoma

SW-620: Human Colon Carcinoma

SU-DHL-10 Human Large Cell Lymphoma

NCI-N87: Human Gastric Carcinoma

Reh (pMMP-Luc-Neo) Human B Cell (Acute Lymphocytic) Leukemia

Raji-luc: Human B-Cell Lymphoma

Ramos: Human B-cell Lymphoma

U-251-luc-mCh-Puro: Human Glioblastoma

SNU-5 Human Gastric Carcinoma

RIF-1: mouse sarcoma

SJSA-1 Human Osteosarcoma

PC-3M-Luc-C6 (Peritibial)

PC-3M-Luc-C6 (Orthotopic)

PC-3M-Luc-C6 (Intracardiac)

PANC-1: Human Pancreatic Carcinoma

SK-OV-3-LUC-D3 (INTRAPERITONEAL)

SK-OV-3 (SUBCUTANEOUS)

OVCAR-8-Luc-mCh-Puro

YUMM1.7: Murine Melanoma

ZR-75-1: Human Mammary Carcinoma (w/estradiol)

NCI-H23: Human Non-Small Cell Lung Carcinoma

NCI-H1975 Human Non-Small Cell Lung Carcinoma

NCI-H1703-LUC-MCH-PURO

NALM6-Luc: Adult B Acute Lymphoblastic Leukemia

MX-1: Human Mammary Carcinoma

MV-4-11-Luc-mCh-Puro: Human Acute Meylogenous Leukemia

MOLT-4-LUC-MCH-PURO

MM.1S (pMMP-Luc-Neo): Human Plasma Cell Myeloma

MIA PaCa-2: Human Pancreatic Ductal Adenocarcinoma

MDA-MB-231-LUC-D3H3

MDA-MB-231-Luc-D3H2LN: Human Mammary Carcinoma

MDA-MB-231-LUC-D3H2

MDA-MB-231-LUC-D3H1

MDA-MB-231-2LMP

MDA-MB-231: Human Mammary Carcinoma

MCF7-LUC-MCH-PURO

MC38: Murine Colon Adenocarcinoma

MB49-LUC-MCH-PURO

MB 49: Murine Bladder Cell Carcinoma

LOX-IMVI: Human Melanoma

LNCAP CLONE FGC

LN-827 (PMMP-LucNeo): Human Glioma

Lewis Lung: Mouse Lung Carcinoma

KP4: Human Pancreatic Ductal Carcinoma

Kg-1-Luc-mCh-Puro: Human Leukemia (AML)

Kasumi-3-Luc-mCh-Puro: Human Leukemia (AML)

Kasumi-1 Human Acute Myeloblastic Leukemia

Jurkat-Clone E6-1

Jurkat: Human Lymphoblastic Leukemia

JJN-3-LUC-G418R

J558-Luc-mCh-Puro

IGROV1: Human Ovarian Carcinoma

ID8-Luc: Murine Ovarian Carcinoma

HT-29: Human Colon Carcinoma

HEPA 1-6-LUC-MCH-PURO

Hep-55.1C-Luc-Mch-Puro

Hep 3B2.1-7: Human Hepatocellular Carcinoma (HCC)

Hel 92.1.7-Luc-Neo

HEKN (Human Epithelial Keratinocytes)

Hek 293-Luc-mCh-Puro

HCT-116: Human Colon Carcinoma

HCC827-LUC-MCH-PURO

HCC70: Human Triple Negative Mammary Carcinoma

GLI36-DSRED-R-LUC (RESCUED)

GL261-Luc2: Mouse Glioma

GIST-T1: Human Gastrointestinal Stromal Tumor

FaDu: Human Pharyngeal Squamous Cell Carcinoma

EMT-6 Murine Mammary Carcinoma

E0771: Murine Mammary Carcinoma

DU 145: Human Prostate Carcinoma

DND-41-LUC-MCH-PURO

DLD-1: Human Colon Carcinoma

Daudi-luc-mCh-Puro: Human B-Cell Lymphoma

D54-Luc: Human Glioma

CT26.WT: Murine Colon Carcinoma

COLO 829: Human Melanoma

COLO 205-LUC #2

COLO 205: Human Colon Carcinoma

Calu-6: Human Lung Adenocarcinoma

CAL 27: Human Tongue Squamous Cell Carcinoma

C51: Mouse Colon Carcinoma

C26: Mouse Colon Carcinoma

C1498-Luc: Murine Leukemia

Bx-PC-3: Human Pancreatic Carcinoma

BT142: Human Oligoastrocytoma (Glioma)

BT-474: Human Mammary Invasive Ductal Carcinoma

BNL 1ME A.7R.1-LUC-MCH-PURO

B16-F10-Luc2: Murine Melanoma

B16-F10: Murine Melanoma

ACHN Human Renal Carcinoma

AB1-LUC-MCH-PURO

A549: Human Lung Carcinoma

A375: Human Melanoma

A20 Murine B Cell Lymphoma

A-498 Human Renal Carcinoma

5TGM1-Luc: Murine Multiple Myeloma

4T1-LUC2: Mouse Mammary Carcinoma

NIH:OVCAR-3-LUC-MCH-PURO

OCI-LY19-LUC-NEO

OCI-LY3-LUC-MCH-PURO

OCI-LY7-LUC-MCH-PURO (RESCUED)

OCI-LY7-LUC-NEO

OCM-1-LUC-MCH-PURO

OVCAR-5-LUC-MCH-PURO

PAN02.TD1-LUC-MCH-PURO

Human Cancer Cell Lines and Growth Curves

OVCAR-3 (PMMP-LUC-NEO): Human ovarian carcinoma – Intra-bursa

OVCAR-3 (PMMP-LUC-NEO): Human ovarian carcinoma – IP

NCI-H1299-Luc: Human Large Cell Lung Carcinoma

SK-MEL-28-Luc-mCh-Puro

SU-DHL-10-LN-HIGH

SU-DHL-4-LUC-MCH-PURO

SU-DHL-6-LUC-MCH-PURO

Oncology and Immuno-oncology Tumor Models | Covance Preclinical

Subcutaneous Tumor Models

Orthotopic Models | Covance Preclinical

Metastasis Models | Covance Preclinical

Disseminated Models | Covance Preclinical

Adoptive Cell Therapies & CAR T | Covance Preclinical

In Vitro Oncology | Covance Preclinical

Immunohistochemistry | Covance Preclinical Oncology

Protein Expression Analysis

DNA / RNA Expression Analysis

Cell and Tissue Processing

Blood and Plasma Analysis

786-O (pMMP-LucNeo) – A model for renal cell carcinoma

GL261: Syngeneic murine glioma model

CT26: Murine colon carcinoma

5TGM1-luc – A syngeneic murine model for multiple myeloma

MDA-MB-231-luc-D3H2LN: A valuable model for triple-negative breast cancer research

Absolute counts by flow cytometry — maximize the accuracy of your immunophenotypic data interpretation

A deeper dive into the tumor-infiltrating T Cell immunophenotype

Comprehensive dendritic cell analysis by flow cytometry using the new CompDC™ panel

Multiplex IHC for patterns of protein expression, co-expression, and spatial relationships

Phospho-protein detection in solid tumors using phospho-flow cytometry

A20: Modeling B cell lymphoma in mice

Subcutaneous and systemic preclinical modeling of A20 murine B cell lymphoma

C1498-Luc-mCherry: A syngeneic acute myeloid leukemia (AML) model

C1498: A murine model for acute myelogenous leukemia (AML)

Colo-205 as a translational imaging model for colorectal cancer

HCC70: A model of triple negative breast cancer

Syngeneic model for preclinical evaluation of ovarian cancer

ID8: A syngeneic mouse model for testing ovarian cancer immunotherapies

MC38: An immunoresponsive murine tumor model | Covance

Focal radiation in the murine 4T1-luc2 mammary cancer model

A549 – A model for non-small cell lung cancer

MV(4;11): A model of human AML (acute myeloid leukemia)

PC-3M-Luc-C6 – a model for prostate carcinoma

E0771 Syngeneic Breast Cancer Model

EMT-6 syngeneic breast tumor model – a powerful tool for immuno-oncology studies

Hepa 1-6: A murine model of hepatocellular carcinoma

Targeting B Cell malignancies? Raji-Luc is a model to test CD19-directed CAR-T cells and other novel approaches

ID8 syngeneic ovarian cancer model response to checkpoint inhibitors

HT-29 as a preclinical model for colorectal cancer

GL261-luc: A model for immunotherapy and radiation therapy

Pan02: A murine model of pancreatic cancer | Covance

4T1-luc2: An orthotopic mammary cancer model to support novel immuno-oncology drug discovery

Prostate cancer modeling with PC-3: One model, four applications

MB49 – a bladder cancer murine tumor model

PyMT – a transplantable murine model of breast cancer

Modeling immuno-oncology in a humanized mouse

Modeling human acute lymphoblastic leukemia (ALL) – using the NALM6-Luc-mCh-Puro model for the development of CAR T cell therapies

Models for non-small cell lung carcinoma

Models for non-small cell lung carcinoma - part 2

LL/2: an immunosuppressive murine tumor model

B16-F10: a murine melanoma model | Covance

Modeling liver cancer with syngeneic hepa 1-6: an update

Pan02 – pancreatic ductal adenocarcinoma model characterized for immuno-oncology applications

MM.1S: A model for multiple myeloma

NCI-H2228 – usage of DCE MRI in a non-small cell lung cancer orthotopic brain metastatis model

Models for pancreatic cancer

Measuring Tumor Antigen-Specific Immunity Through ELISpot and FluoroSpot

Reconstructed Bone, plate-based 3D culture assay

BT-474 Human ductal breast carcinoma: New life for an old model

Update on the preclinical use of hPBMC for immuno-oncology modeling

Functional Analysis of Tumor Infiltrating Lymphocytes by Flow Cytometry Using the Cytokine/Cytotoxicity™ Panel

Bioluminescence imaging: In vivo monitoring of tumor development, disease dissemination and treatment efficacy

Pan02-Luc: An orthotopic model of pancreatic cancer

Determining preclinical CAR T-cell persistence by flow cytometry

CT26-Luc: An orthotopic murine model of colon cancer: implications for immuno-oncology studies

Preclinical Oncology: 2020 Spotlight Roundup | Covance

EMT6-Luc: In vivo monitoring of metastatic development and treatment efficacy

Oncology Posters | Covance Preclinical

Systemic and subcutaneous modeling of A20 murine B cell lymphoma in mice: A comparative assessment

Focal radiation enhances paclitaxel therapy in a mouse model of triple negative breast cancer

ID8-Luc syngeneic ovarian cancer model for preclinical evaluation of immunomodulatory molecules

Combined focal radiation and anti-mCTLA-4 antibody therapy modulates myeloid subset phospho-stat3 levels in the 4T1 tumor microenvironment, and results in tumor growth inhibition

High-throughput analysis of MAPK and JAK-STAT signaling in CT26 tumors using a combination of immunophenotyping and phospho-flow cytometry

Characterization of proliferation in multiple lymphocyte subsets in the CT26 murine colon carcinoma model by multi-color flow cytometry

Combination of a glycomimetic antagonist to E-selectin and CXCR4, GMI-1359, with an anti-PD-L1 antibody attenuates regulatory T Cell infiltration and accelerates time to complete response in the murine CT26 tumor model

In-depth myeloid cell characterization in the murine syngeneic CT.26 colon carcinoma model by 10-color flow cytometry

Comprehensive 10-color flow cytometry analysis of the neuroblastoma intratumoral immune response using the murine syngeneic Neuro-2a tumor model

Preclinical models of multiple myeloma

Radiation enhances anti-tumor activity of checkpoint blockade in syngeneic tumor models

Preclinical assessment of anti-tumor activity and immune response in syngeneic tumor models

Sensitivity of syngeneic tumor models to focal radiation

Combination of rapamycin with immune checkpoint blockade in a syngeneic breast carcinoma model

Image-guided focal irradiation in syngeneic preclinical oncology mouse models

Anti-mCTLA-4 treatment results in early and late immune response effects in a murine model of colorectal carcinoma

Preclinical use of focal radiation and immune checkpoint blockade to improve therapeutic response in an immunologically cold tumor

Evaluation of the immune response following treatment with anti‐CTLA‐4 antibody, radiation therapy or the combination in a murine model of breast cancer

Combined dynamic 18F-FDG PET imaging and DCE prediction of treatment response in an orthotopic model of glioblastoma multiforme

Radiation response in preclinical orthotopic models of brain cancer

Evaluation of immunomodulatory agents in classically immunologically “cold” cancers using syngeneic mouse models of breast and ovarian cancer

Preclinical response of murine syngeneic tumor models to immune checkpoint inhibitor antibodies

A comparative evaluation of immunotherapy responses in murine colon carcinoma

Imaging the future | Published in the European Biopharmaceutical Review

TIGIT directed human antibody modulates T-regulatory and effector cell function

Oncology & Hematology Clinical Trial Development | Covance

Meet the Oncology & Hematology Medical Consulting Team | Covance

Patient Recruitment | Covance

Immuno-Oncology & Immunotherapy CRO | Covance Preclinical & Nonclinical

Preclinical Immunotherapy CRO | Covance

Immuno-Oncology Clinical Trial Development CRO | Covance

Oncology Treatment Development Resources | Covance CRO

Top 5 Design Considerations for Preclinical Immuno-oncology Studies

Top 5 Models for Immuno-oncology Studies

Oncology & Immuno-oncology Events | Covance

Precision Medicine Applications in Oncology Webinar Series | Covance

IND/CTA Enabling Studies

Lung, Respiratory and Pulmonary Development | Covance

In Vivo & In Vitro Respiratory Disease Models | Covance Nonclinical

Respiratory & Lung Disease | Covance Clinical Trials

Lung, Respiratory, Pulmonary and Inhalation Resources | Covance

Global CRO Drug Development Services | Covance

Lead Optimization Non-GLP Toxicology

Computed Tomography (CT) Services

Flow Cytometry Services

Drug Analysis Services

Bioanalytical Laboratory Solutions & Services

LC-MS Immunoanalytical Solutions

Bioanalytical Method Development & Validation

Preclinical and Clinical Sample Analysis

Immunoanalytical Solutions

Specialty LC-MS Support

Targeted Proteomics

Discovery Bioanalysis

Vaccine Analysis

Analytical Methods for Bioanalysis

Bioanalysis Education Center

Drug Metabolism and Pharmacokinetics (DMPK), Including ADME Studies | Covance

In Vitro Metabolism Services | Covance Nonclinical

Enzyme Induction Services | Covance Nonclinical

Enzyme Inhibition Services | Covance Nonclinical

Metabolic Stability Studies & Services | Covance Metabolism

Metabolism Protein Binding Studies & Services | Covance Preclinical

Reaction Phenotyping Studies & Services | Covance Preclinical

Drug Transporter Interactions & Drug-Drug Interactions (DDIs) | Covance Metabolism

In Vivo Metabolism Services & Studies | Covance Nonclinical

Metabolite Identification Studies & Services | Covance Metabolism

Human AME (hAME) Studies | Covance Metabolism

Metabolism & Pharmacokinetic Events | Covance

Modeling, In Silico and Pharmacometric Studies | Covance Nonclinical

Compartmental PK Analysis & Modeling | Covance

PK/PD Modeling & Simulation Services | Covance Nonclinical

PBPK Analysis & Modeling | Covance

Quantiative and/or Systems Pharmacology (QSP / SP) Modeling | Covance

Custom Antibody Reagents

Lead Optimization Services

Lead Optimization Non-GLP Toxicology

Core Lead Optimization Toxicology Services

Safety Assessment Non-GLP Toxicology

In Vivo Pharmacology & Disease Model Development

Comprehensive Leukocyte Quantitation

Oncology Cell Line Assays

PK Study & PK/TK (Pharmacokinetics & Toxicokinetics) Analysis and Reporting

Nonclinical Imaging Services

Computed Tomography (CT) Services

Bioluminescence Imaging

Image Analysis Services

Positron Emission Services

Radiation Nonclinical CRO Services

Flow Cytometry Services

Vaccine Discovery Testing

Crop & Chemical Product Testing

Crop Protection Product Testing

Crop Protection Education Center

Human Safety - Toxicology

Developmental and Reproductive Toxicology (DART)

Genetic Toxicology

In Vitro Alternative Test Methods

General Toxicology

Regulatory Consultancy

Registration and Submission

Classification Labeling and Safety Data Sheets

Biocide Regulation in Europe

Authorization of biocidal products in Europe

Endocrine Disruptors

Endocrine Disruptor (ED) Testing across the World

Regulatory Support for Endocrine Disruptors

Physical Chemistry

Physicochemical Properties of Active Ingredients

Physicochemical Properties and Technical Characteristics of Formulated Products

Environmental Safety

Aquatic Ecotoxicology

Terrestrial Ecotoxicology

Environmental Fate and Metabolism

Environmental Fate

Comparative In Vitro Metabolism

Plant Metabolism

Animal Metabolism

Livestock Metabolism Studies

Lab Animal Metabolism

Dermal Absorption

Residue Analysis Services (RAS)

Chemical Testing

Crop Protection & Chemical Sites | Covance

Shanghai Facility | Covance

Ann Arbor, MI Facility | Covance

Madison, WI Facility | Covance

Harrogate, UK Facility | Covance

Denver, PA Facility | Covance

Eye, UK Facility | Covance

Greenfield, IN Location | Covance

Huntingdon, UK Facility | Covance

Münster, GD Facility | Covance

Shardlow, UK Facility | Covance

Somerset, NJ Facility | Covance

Toxicologic Pathology | Covance Preclinical CRO

Anatomic Pathology CRO Services | Covance

Clinical Pathology | Covance Preclinical CRO

Specialty Pathology Techniques | Covance Preclinical CRO

Immunohistochemistry (IHC) Services | Covance Nonclinical

Electron Microscopy (TEM) | Covance Nonclinical

Chemistry, Manufacturing and Controls (CMC) Support

Biopharm CMC Manufacturing Solutions | Covance

BIOCMC Analytical Solutions Education Center

Toxicology: Safety Assessment | Covance

General Toxicology | Covance

SEND - Standard for the Exchange of Nonclinical Data | Covance

Core Toxicology Services | Covance

Drug Abuse Liability Solutions | Covance

Infusion Toxicology Services | Covance

Juvenile Studies | Covance

Neurotoxicity Studies | Covance

Nonhuman Primate Studies | Covance

Ocular Development Services | Covance

Genetic Toxicology Studies | Safety Assessment | Covance

Regulatory Assays | Genetic Toxicology | Covance

Genetic Toxicology Screening Studies | Covance

Multi-endpoint Genetic Toxicology Assays | Covance

Immunotoxicology | Drug Development Services | Covance

Safety Pharmacology | Covance Preclinical CRO

Safety Pharmacology | Cardiovascular Assessment | Covance

Safety Pharmacology | ICH Core Battery Tests | Covance

Safety Pharmacology | ICH Studies and Supplemental Tests | Covance

Safety Pharmacology | Drug Discovery Support | Covance

Safety Pharmacology | Neurotoxicology Study Services | Covance

Safety Pharmacology | Infusion Safety Pharmacology Services | Covance

Drug Abuse Assessment Education Center

Developmental and Reproductive Toxicology | Covance

SEG I: Fertility and Early Embryonic Development | Covance

SEG II: Embryo Fetal Development | Covance

SEG III: Prenatal and Postnatal Development | Covance

EPPND: Enhanced Pre- and Post-Natal Development Services | Covance

Juvenile Toxicity Studies | Covance

Special Evaluation Techniques | Covance

Infusion Services | Covance

SEND 3.1 Standard for the Exchange of Nonclinical Data | Covance

SEND Education Center

Routes of Administration | Covance Nonclinical

Inhalation Toxicology | Covance Nonclinical

Pharmaceutical Consulting | Covance

Molecule Development Group

Alliance Management

Molecule Development Group | Consulting Services | Covance

Drug Development Alliance Management Consulting | Covance

Early Phase Development Solutions | Covance

Drug Development Consulting | Covance

Access & Strategy

Evidence Generation

Data Capabilities

Design Better Studies | Xcellerate - Covance

Improve Study Recruitment | Xcellerate - Covance

Reduce Study Risk | Xcellerate - Covance

Gain Operational Insights | Xcellerate - Covance

Ensure Data Quality | Xcellerate - Covance

Access Central Laboratory Information | Xcellerate - Covance

Empower Your Data | Xcellerate - Covance

Maximize Product Access | Xcellerate - Covance

Transform Patient Safety | Xcellerate - Covance

Clinical Development Services | Covance

Clinical Pharmacology / Phase I in Drug Development | Covance

Clinical Pharmacology Education Center | Covance

Early Clinical Development Phase (IIa) | Covance

Clinical Research Unit Virtual Tours | Covance

Phase IIb Clinical Trials/Phase III Clinical Trials

Clinical Data Management Analysis and Reporting | Covance

Global Regulatory Affairs & Product Development Consulting | Covance

Phase IV | Covance

Virtual Clinic Tours

Clinical-Biotech | Covance

Decentralized Clinical Trials | Covance

Decentralized Clinical Trials (DCT) Education Center | Covance

Clinical Trial Laboratory Services | Covance

Clinical Laboratory Services | Covance Central Labs

Companion Diagnostics

Europe, Middle East and Africa

United States, Canada and Puerto Rico

SpecimINSIGHT™/GlobalCODE® – Pipeline Data Management Solutions Powered by Global Specimen Solutions®

Patient Service Centers

Discover Unrealized ROI With GlobalCODE® End-to-End Specimen Management

Specialty Testing

Flow Cytometry Solutions | Covance

Translational Biomarker Solutions | Covance

Vaccines and Immunology | Covance

Assays to Support Vaccines and Novel Immunotherapeutics

Vaccines Education Center | Covance

Expanded Lab Management Solutions

Precision Medicine Solutions

Biomarker Solutions, Designed Around You | Covance

Biomarker Solution Center | Covance

Companion Diagnostics (CDx) - Clinical Testing Services | Covance

Genomics Services

Cell and Gene Therapy Solutions | Covance

Cell and Gene Therapy Expert Teams | Covance

Cell Therapies | Covance

Gene Therapies | Covance

Immuno-Oncology

Preclinical Immunotherapy CRO | Covance

Immuno-Oncology Clinical Trial Development CRO | Covance

Bioanalytical Services

Analytical Methods for Bioanalysis

Bioanalysis Education Center

BIOCMC Analytical Solutions Education Center

Alliance Management

Assays to Support Vaccines and Novel Immunotherapeutics

Vaccines Education Center | Covance

Functional Service Provider Model: Covance FSPx

Functional Service Provider Model: Covance FSPx Education Center

Drug Commercialization and Pharma Services | Covance

Patient Support Programs

Access and Strategy | Covance Market Access

Evidence Generation | Covance Market Access

Value Communication | Covance Market Access

Patient Support Services | Covance Market Access

Patient Assistance Programs

Field Services | Covance Market Access

Covance Market Access - Asia-Pacific

Access and Strategy

Evidence Generation

Value Communication

Patient Support Services | Covance

Patient Access Programs 2020 Events

Phase IV Solutions

Patient Safety and PV Services (Pharmacovigilance): From Adverse Events to Signal Detection and Risk Management | Covance

PV Services | Covance

Aggregate Reporting and Safety Writing | Covance

Signal Detection Pharmacovigilance and PV Risk Management | Covance

Patient Safety Consulting for Drug and Medical Development | Covance

Integrated Drug Safety Technology Solutions | Covance

Patient Safety Solutions Resource Center | Covance

Pharmacovigilance Automation

Biomarker Solutions, Designed Around You | Covance

Solutions Designed Distinctly for the Nimble and Progressive Biopharma Venture

The Hub - Designed Around You | Covance

Take on Evolving Drug Development Challenges with Partnership Designed Around You^®

Clinical Trial Investigators | Covance

Order a Kit | Covance

Become a Clinical Trial Investigator | Covance

Accreditations and Certifications | Covance

Current Investigator & Study Staff | Covance

Courier Contact Numbers

UPS Express Critical Label

Institution Privacy Statement

Investigator Privacy Statement

Study Staff Privacy Statement

Packaging and Shipping Videos

Sample Collection Videos

Frequently Asked Questions

Participate in a Trial

Covance Medical Device & Diagnostic Solutions

Regulatory & Consulting

Preclinical and Experimental Surgery Solutions

Clinical & Market Approval

Commercial & Post-Market Support

Medical Device Education Center | Covance

Consultant Connection | Covance

Latest Thinking

Resources: Scientific & educational insights on pharmaceutical & product development | Covance

KL Search Page Custom

Corporate Responsibility | Covance

Our Commitment as Insightful CRO Partners | Covance

Our Commitment as Relentless CRO Collaborators | Covance

Code of Respect

Our Commitment to Animal Welfare

Why Animal Research

Impact on Results

Beliefs in Action

Brexit Update | Covance

Unsubscribe Confirmation

Covance Preference Center

Upcoming Events and Webinars

Covance Webinars

Scientific Symposiums

Events Twitter Feed

Connect with Us at SCOPE, March 2-4

Design Better Studies | Covance

Xcellerate Protocol Design Tool | Covance

Xcellerate Patient Intelligence | Covance

Improve Study Recruitment | Covance

Xcellerate Recruitment Analysis & Forecasting | Covance

Xcellerate Site List Tool | Covance

Xcellerate Spatial Cluster Analysis | Covance

Reduce Study Risk | Covance

Xcellerate Risk Assessment & Categorization Tool | Covance

Xcellerate Risk & Issue Management | Covance

Xcellerate Risk Review | Covance

Gain Operational Insights | Covance

Xcellerate Action Alerts

Xcellerate CRA Dashboard

Xcellerate Study Dashboard

Xcellerate Portfolio Dashboard

Ensure Data Quality | Covance

Xcellerate Medical Review

Xcellerate Statistical Review

Xcellerate Data Review

Access Central Lab Information | Covance

Xcellerate Lab Sponsor Portal

Xcellerate LabLink+

Xcellerate Lab Investigator Portal

Empower Your Data | Covance

Xcellerate Clinical Data Warehouse

Xcellerate Operational Data Warehouse

Maximize Product Access | Covance

Xcellerate Patient Access Toolkit | Covance

Xcellerate Patient Support BI Dashboard | Covance

Transform Patient Safety | Covance

Xcellerate Case Management

Xcellerate Safety Reporting

Covance Business Unit Names New Leaders

COVID-19 Vaccine Development | Covance

COVID-19 Vaccine & Antiviral Preclinical Development and Testing | Covance

COVID-19 Trial Design & Patient Recruitment | Covance Clinical

COVID-19 Clinical Testing & Labs | Covance

COVID-19 Treatments: Commercialization & Reimbursement | Covance

COVID-19: Medical Device and Diagnostic Solutions | Covance

COVID-19 Product Testing for Crops or Chemicals | Covance

Coronavirus (COVID-19) Updates | Covance

COVID-19 Clinical Trial Connect | Covance

LabCorp Careers Investigators Order a Kit Trial Share CT Portal Clinical Trials

Home Contact Us Preference Center Privacy Locations Terms of Use Cookie Statement Animal Welfare

Suppliers Investors Press & News Combatting Modern Slavery and Human Trafficking Statement Events and Webinars Careers Site Map